Hansa Biopharma AB
HNSA SE0002148817
ICB 2010 : Health Care / Health CareSweden 220 07
SE-M Lund Box 785
Registration Number 556734-5359
Founded 2007
Previous Name(s):
Hansa Medical AB
Annual Performance 1
2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
203% | -62% | -45% | -49% | 44% |
Historical Performance 1
1M | 3M | 6M | 1Y | 3Y | 5Y | All Time |
---|---|---|---|---|---|---|
23% | -1% | 30% | -13% | -85% | -81% | 728% |
Annual Insiders Turnover, USD 2
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
5,728,802.48 | 1,388,050.01 | 30,585.84 | 276,082.40 | 387,653.55 | 11,018.35 | 115,625.14 |
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 66 Insiders: 21
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Sören Tulstrup CEO |
0.00 SEK |
35,200 Bought |
0 SEK |
21/06/2024 | 17/06/2024 |
Anne Säfström Lanner EX OFF |
0.00 SEK |
17,600 Bought |
0 SEK |
25/06/2024 | 17/06/2024 |
Achim Kaufhold O |
0.00 SEK |
17,600 Bought |
0 SEK |
21/06/2024 | 17/06/2024 |
Sören Tulstrup CEO |
42.27 SEK |
9,199 Sold |
388,842 SEK |
21/06/2024 | 17/06/2024 |
Anne Säfström Lanner EX OFF |
42.27 SEK |
10,487 Sold |
443,285 SEK |
25/06/2024 | 17/06/2024 |
Peter Nicklin CB |
38.88 SEK |
10,000 Bought |
388,800 SEK |
08/02/2024 | 06/02/2024 |
Sören Tulstrup CEO |
23.03 SEK |
5,000 Bought |
115,142 SEK |
08/12/2023 | 07/12/2023 |
Peter Nicklin CB |
71.19 SEK |
14,500 Bought |
1,032,193 SEK |
02/08/2022 | 19/07/2022 |
Christian Kjellman O |
49.99 SEK |
6,915 Bought |
345,681 SEK |
21/06/2022 | 17/06/2022 |
Christian Kjellman O |
49.99 SEK |
4,002 Sold |
200,060 SEK |
21/06/2022 | 17/06/2022 |